Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N HARTMANN

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Immunology|December 17, 2009
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-BMarion Leick, Julie Catusse, Marie Follo, et al.
Schizophrenia Research|November 4, 2015
The association of neurocognitive impairment with diminished expression and apathy in schizophreniaMatthias N Hartmann-Riemer, Oliver M Hager, Matthias Kirschner, et al.
Neuroscience Letters|January 11, 2015
Enhanced calcium responses to serotonin receptor stimulation in T-lymphocytes from schizophrenic patients--a pilot studyJ Genius, A Schellenberg, L Tchana-Duope, et al.
Frontiers in Immunology|March 9, 2023
Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis modelAgatha Schwarz, Rebecca Philippsen, Serena G Piticchio, et al.
Schizophrenia Research|August 14, 2021
How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domainMariia Kaliuzhna, Matthias Kirschner, Fabien Carruzzo, et al.
Ecotoxicology (London, England)|May 28, 2014
Uptake and depuration of gold nanoparticles in Daphnia magnaL M Skjolding, K Kern, R Hjorth, et al.
Schizophrenia Research|May 1, 2020
Clinical, behavioural and neural validation of the PANSS amotivation factorMariia Kaliuzhna, Matthias Kirschner, Fabien Carruzzo, et al.
Tobacco Induced Diseases|September 19, 2025
Mouse model validity for studying the impact of tobacco smoke on the human gut microbiota assessed via in silico and experimental approachesIrene Victoria Bermúdez-Pérez, Juliana Meißner, Corinna Bang, et al.
BMC Psychiatry|November 24, 2016
The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathyMartin Bischof, Caitriona Obermann, Matthias N Hartmann, et al.
Scientific Reports|January 11, 2017
Deficits in reinforcement learning but no link to apathy in patients with schizophreniaMatthias N Hartmann-Riemer, Steffen Aschenbrenner, Magdalena Bossert, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Immunology|December 17, 2009
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-BMarion Leick, Julie Catusse, Marie Follo, et al.
Schizophrenia Research|November 4, 2015
The association of neurocognitive impairment with diminished expression and apathy in schizophreniaMatthias N Hartmann-Riemer, Oliver M Hager, Matthias Kirschner, et al.
Neuroscience Letters|January 11, 2015
Enhanced calcium responses to serotonin receptor stimulation in T-lymphocytes from schizophrenic patients--a pilot studyJ Genius, A Schellenberg, L Tchana-Duope, et al.
Frontiers in Immunology|March 9, 2023
Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis modelAgatha Schwarz, Rebecca Philippsen, Serena G Piticchio, et al.
Schizophrenia Research|August 14, 2021
How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domainMariia Kaliuzhna, Matthias Kirschner, Fabien Carruzzo, et al.
Ecotoxicology (London, England)|May 28, 2014
Uptake and depuration of gold nanoparticles in Daphnia magnaL M Skjolding, K Kern, R Hjorth, et al.
Schizophrenia Research|May 1, 2020
Clinical, behavioural and neural validation of the PANSS amotivation factorMariia Kaliuzhna, Matthias Kirschner, Fabien Carruzzo, et al.
Tobacco Induced Diseases|September 19, 2025
Mouse model validity for studying the impact of tobacco smoke on the human gut microbiota assessed via in silico and experimental approachesIrene Victoria Bermúdez-Pérez, Juliana Meißner, Corinna Bang, et al.
BMC Psychiatry|November 24, 2016
The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathyMartin Bischof, Caitriona Obermann, Matthias N Hartmann, et al.
Scientific Reports|January 11, 2017
Deficits in reinforcement learning but no link to apathy in patients with schizophreniaMatthias N Hartmann-Riemer, Steffen Aschenbrenner, Magdalena Bossert, et al.
Pageof 12